Telehealth Virtual Visits Software is Launched by Seattle Based MedBridge

The offer is intended to provide crucial help to healthcare organizations and their patients throughout the COVID-19 crisis by allowing providers to manage the care of their patients remotely.

Healthcare organizations and professionals across the care continuum are now being confronted with equally difficult challenges. Many outpatient organizations are experiencing steep revenue loss as patients cancel or defer appointments due to quarantine, social distancing protocols, and concerns overexposure. Post-acute care clients, including those in skilled nursing and home health, must adjust care delivery to keep both their staff and patients safe. In response, MedBridge launched its Telehealth solution to be available as a beta version several months sooner than planned.

MedBridge is here to support our customers, their patients, and their communities during this challenging time and beyond. We’re committed to helping everyone weather this crisis and stay prepared during every stage with innovative solutions for remote care and education as we all adjust to a new paradigm,” said Justin Kowalchuk, CEO, and founder of MedBridge.

MedBridge Telehealth allows providers to remotely screen, triage, and care for patients in real-time, providing a HIPAA-compliant method for continuing treatment plans during the ongoing COVID-19 crisis. Providers can also foster rapport, engagement, and education by building, sharing, and discussing targeted home exercises with their patients during each virtual visit.

“Telehealth Virtual Visits offers a patient experience that’s as close as possible to an in-person session. It’s easy to implement, use, and learn for clinicians and patients, which is essential now that healthcare professionals are in crisis mode. Because it allows for uninterrupted care, it can be used to optimize long-term outcomes by rehab providers across the care continuum,” said Keta Shaw, Telehealth Product Manager, MedBridge.

The Virtual Visit software is part of the complete MedBridge Digital Patient Engagement Suite, which includes program adherence tracking, in-app messaging, and satisfaction monitoring to help patients self-manage and stay active in their plan of care while they’re confined to their home. The virtual patient care solution, paired with MedBridge’s remote training, infection prevention, and crisis management education, offers healthcare organizations a complete solution to combat the challenges of this time.

SourceMedBridge

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”